We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Liberate Medical Stock

Invest in or calculate the value of your shares in Liberate Medical or other pre-IPO companies through EquityZen's platform.

Get Started

Liberate Medical Stock (LIBM)

Liberate Medical licenses a technology that is synchronized with a patient's breathing cycle.

About Liberate Medical Stock

Founded

2013

Headquarters

Crestwood, KY, US

Industries

Science and Engineering, Health Care, Biotechnology

Liberate Medical is a medical device company that uses non-invasive respiratory muscle stimulation to reduce the cost and improve the quality of care for patients with pulmonary disorders. It licenses a platform technology, based on electrical stimulation of the abdominal muscles that is synchronized with a patient's breathing cycle. The company's proprietary technology uses electrical muscle stimulation to activate the expiratory muscles in synchrony with exhalation. Founded in 2013, Liberate Medical is headquartered in Crestwood, Kentucky.

Liberate Medical Press Mentions

Stay in the know about the latest news on Liberate Medical

Liberate Medical Management

Leadership team at Liberate Medical

Co-Founder / CEO

Angus Mclachlan

Director

Cedric Francois

Locked Features

Join now and verify your accreditation status to gain access to:

  • Liberate Medical Current Valuation
  • Liberate Medical Stock Price
  • Liberate Medical Management
  • Available deals in Liberate Medical and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Liberate Medical Cap Table and Funding History by Share Class and Liquidity Preferences
    • Liberate Medical Revenue and Financials
    • Liberate Medical Highlights
    • Liberate Medical Business Model
    • Liberate Medical Risk Factors
  • Liberate Medical Research Report from SACRA Research
Join Now

Trading Liberate Medical Stock

How to invest in Liberate Medical stock?

Accredited investors can buy pre-IPO stock in companies like Liberate Medical through EquityZen funds. These investments are made available by existing Liberate Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Liberate Medical stock?

Shareholders can sell their Liberate Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."